Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$120,000.00

Assessing the impact of bacteria exchange during penile-vaginal sex on genital immunology and HIV susceptibility in Ugandan couples

EF 2024-25

Résumé
Human immunodeficiency virus (HIV) transmission rates are disproportionately high among African, Caribbean, and other Black (ACB) individuals in sub-Saharan Africa. High HIV risk may be linked to an imbalance of bacteria in the genital tract. Bacterial vaginosis (BV), a clinical condition characterized by an overgrowth of "harmful" bacterial species instead of "healthy" Lactobacillus species in the vagina, increases HIV risk by 60% by causing vaginal inflammation. While standard antibiotic BV treatment reduces vaginal inflammation by clearing harmful bacteria, its impact on heterosexual HIV transmission is unknown. We have recently found that penile-vaginal sex induces a 48-72h window of genital inflammation in Toronto couples, which coincides with the timing of HIV infection. While the exchange of genital bacteria during condomless sex contributes to inflammation, how the genital tract counteracts it is poorly understood. Our clinical study tests a novel treatment strategy to reduce the inflammation induced by sex amongst heterosexual couples in Uganda, where HIV and BV rates are high. By providing BV treatment to female partners before sex, we expect to clear harmful bacteria, reduce vaginal inflammation, and lower female HIV risk. BV treatment may also reduce the transfer of harmful vaginal bacteria to the penis during sex, thereby reducing male HIV risk. Additionally, we will assess other immunological components in the vagina to evaluate how they protect against inflammation after sex. The accessibility of HIV medications falls short of target goals, especially for ACB individuals globally, emphasizing the need for better prevention strategies. This study aims to offer alternative clinical interventions to reduce HIV risk and address the stigma surrounding it. Findings will be shared with local Toronto HIV clinics, international HIV conferences, and communities in Uganda to advance HIV prevention efforts.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
518371
Name
Tsang Tsz Sin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Assessing the impact of bacteria exchange during penile-vaginal sex on genital immunology and HIV susceptibility in Ugandan couples
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Antibiotics; Bacterial Vaginosis; Cytokines And Chemokine; Genital Inflammation And Immunology; Genital Microbiome And Bacteria; Hiv Acquisition Risk; Microbiology; Qpcr And Rna Sequencing; Sub-Saharan Africa; Translational Research
Abstract
Human immunodeficiency virus (HIV) transmission rates are disproportionately high among African, Caribbean, and other Black (ACB) individuals in sub-Saharan Africa. High HIV risk may be linked to an imbalance of bacteria in the genital tract. Bacterial vaginosis (BV), a clinical condition characterized by an overgrowth of "harmful" bacterial species instead of "healthy" Lactobacillus species in the vagina, increases HIV risk by 60% by causing vaginal inflammation. While standard antibiotic BV treatment reduces vaginal inflammation by clearing harmful bacteria, its impact on heterosexual HIV transmission is unknown. We have recently found that penile-vaginal sex induces a 48-72h window of genital inflammation in Toronto couples, which coincides with the timing of HIV infection. While the exchange of genital bacteria during condomless sex contributes to inflammation, how the genital tract counteracts it is poorly understood. Our clinical study tests a novel treatment strategy to reduce the inflammation induced by sex amongst heterosexual couples in Uganda, where HIV and BV rates are high. By providing BV treatment to female partners before sex, we expect to clear harmful bacteria, reduce vaginal inflammation, and lower female HIV risk. BV treatment may also reduce the transfer of harmful vaginal bacteria to the penis during sex, thereby reducing male HIV risk. Additionally, we will assess other immunological components in the vagina to evaluate how they protect against inflammation after sex. The accessibility of HIV medications falls short of target goals, especially for ACB individuals globally, emphasizing the need for better prevention strategies. This study aims to offer alternative clinical interventions to reduce HIV risk and address the stigma surrounding it. Findings will be shared with local Toronto HIV clinics, international HIV conferences, and communities in Uganda to advance HIV prevention efforts.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tsang, Tsz Sin
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~